Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis

Successful Treatment of Old World Cutaneous Leishmaniasis Caused byLeishmania infantumwith Posaconazole

(2011) A. E. Paniz Mondolfi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Therapeutic evaluation of free and liposome-loaded furazolidone in experimental visceral leishmaniasis

(2010) André Gustavo Tempone et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Topical delivery andin vivoantileishmanial activity of paromomycin-loaded liposomes for treatment of cutaneous leishmaniasis

(2010) Guilherme Carneiro et al.   JOURNAL OF LIPOSOME RESEARCH

Current Treatment for Cutaneous Leishmaniasis: A Review

(2009) Emilio Palumbo   AMERICAN JOURNAL OF THERAPEUTICS

Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens

(2009) M. G. Aguiar et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Respiratory delivery of theophylline by size-targeted starch microspheres for treatment of asthma

(2009) Arash Momeni et al.   JOURNAL OF MICROENCAPSULATION

Reduced Tissue Parasitic Load and Infectivity to Sand Flies in Dogs Naturally Infected by Leishmania (Leishmania) chagasi following Treatment with a Liposome Formulation of Meglumine Antimoniate

(2008) R. R. Ribeiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Trifluralin liposomal formulations active against Leishmania donovani infections

(2008) Manuela Carvalheiro et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Atomic force microscopy imaging of novel self-assembling pectin–liposome nanocomplexes

(2007) Pornsak Sriamornsak et al.   CARBOHYDRATE POLYMERS